Uppsala, 24 June 2021. On 23 June 2021, Senzime AB (publ) announced that Nasdaq Stockholm’s Listing Committee had approved that the company’s shares are admitted to trading on Nasdaq Stockholm’s main market, conditioned upon customary conditions being fulfilled. The prospectus prepared in connection with the listing has today been approved and registered by the Swedish Financial Supervisory Authority and is now available on Senzimes website www.senzime.com and will be made available on the Swedish Financial Supervisory Authority’s website www.fi.se.
Link to prospectus (only available in Swedish): [Prospectus Senzime AB 2021]
The first day of trading on Nasdaq Stockholm’s main market is scheduled for Wednesday 30 June 2021 and the last day of trading on Nasdaq First North Growth Market is scheduled for Tuesday 29 June 2021. The shares will be traded under the same ticker (SEZI) and ISIN-code (SE0002478776). There is no offering or issue new shares in connection with the list change, and shareholders in Senzime do not need to take any actions.
Advokatfirman Lindahl has acted as legal advisor in connection with the listing on Nasdaq Stockholm.
N.B. English translation is for convenience purposes only.